<DOC>
	<DOCNO>NCT01504711</DOCNO>
	<brief_summary>This clinical trial study fosaprepitant dimeglumine prevent nausea vomit patient gastrointestinal cancer receive combination chemotherapy . Antiemetic drug , fosaprepitant dimeglumine , may help lessen prevent nausea vomit patient treated chemotherapy .</brief_summary>
	<brief_title>Fosaprepitant Dimeglumine Preventing Nausea Vomiting Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate efficacy addition fosaprepitant ( fosaprepitant dimeglumine ) control acute delay vomit standard prophylactic anti-emetic combination 5-HT3 receptor antagonist dexamethasone gastrointestinal cancer patient receive FOLFIRINOX ( 5-FU [ fluorouracil ] , oxaliplatin irinotecan [ irinotecan hydrochloride ] ) chemotherapy . II . To determine rate complete response ( emetic episode rescue medication ) combine acute delayed phase 0-120 hour chemotherapy . SECONDARY OBJECTIVES : I . To determine incidence nausea vomit acute ( &lt; 24 hour ) delay ( 24- 120 hour ) set patient receive FOLFIRINOX chemotherapy . TERTIARY OBJECTIVES : I . Follow overall survival patient receive FOLFIRINOX chemotherapy . OUTLINE : Patients receive fosaprepitant dimeglumine intravenously ( IV ) 30 minute prior FOLFIRINOX chemotherapy . After completion study treatment , patient follow 2 month .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<criteria>Patient receive FOLFIRINOX chemotherapy Southwest Oncology Group ( SWOG ) Performance status 0 1 Ability patient guardian understand provide voluntary write informed consent Patient current illness require chronic systemic steroid use require chronic use anti emetic Patients gastrointestinal ( GI ) obstruction active peptic ulcer disease take oral medication Known hypersensitivity component study regimen Patients take follow medication : Oral contraceptive ( except administration stop menses ) , tolbutamide , phenytoin , midazolam , ketoconazole , rifampin , paroxetine , Diltiazem Pregnant nursing woman Patients use illegal drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>